Narcotic and psychotropic medicines in Russia and the EAEU. Circulation license, import and export, distribution
Narcotic drugs and psychotropic substances of Lists I and II are imported into Russia and exported from Russia by Lomonosov Moscow State University (MSU), which uses them for scientific and educational purposes and in expert activities, and by state unitary enterprises. This is established by Federal Law No. 3-FZ of 8 January 1998 «On Narcotic Drugs and Psychotropic Substances» (hereinafter 3-FZ). List I includes substances whose circulation is prohibited, and List II includes substances with restricted circulation. Psychotropic substances of List III (circulation is restricted, and some control measures may be waived) are imported and exported by legal entities of any form of ownership if they hold a license for the right to import or export.
Licensing of the circulation of these substances is governed by the Regulation on Licensing of Activities in the Circulation of Narcotic Drugs, Psychotropic Substances and Their Precursors and the Cultivation of Narcotic Plants (hereinafter the Licensing Regulation), which was approved by Resolution of the Government of the Russian Federation No. 1007 of 2 June 2022 (hereinafter Resolution No. 1007). The Licensing Regulation is valid until 1 September 2028. The Rules for the Distribution, Sale and Dispensing of Narcotic Drugs and Psychotropic Substances were approved by Resolution of the Government of the Russian Federation No. 1871 of 30 October 2021 (hereinafter Resolution No. 1871) and are valid until 1 March 2028.
Which acts are in force and until what date
The legislation on narcotic drugs and psychotropic substances consists of 3-FZ, other federal laws and the acts adopted under them. The legislation on the circulation of medicines applies to medicines containing such substances to the extent that it does not contradict 3-FZ. The validity period of each act in Table 1 is stated according to the text of the act itself.
Table 1. Acts by type of activity and their validity periods
| Subject | Act | Valid until | Repealed on adoption of |
|---|---|---|---|
| Licensing | Resolution No. 1007 (as amended on 13 June 2024) | 1 September 2028 | Resolution of the Government of the Russian Federation No. 1085 of 22 December 2011 |
| Distribution, sale and dispensing | Resolution No. 1871 | 1 March 2028 | Resolution of the Government of the Russian Federation No. 558 of 26 July 2010 |
Lists in the Controlled Substances List and organizations allowed to engage in circulation
The List of Narcotic Drugs, Psychotropic Substances and Their Precursors Subject to Control in the Russian Federation (hereinafter the Controlled Substances List) is approved by the Government. The current Controlled Substances List was approved by Resolution of the Government of the Russian Federation No. 681 of 30 June 1998 (as amended on 11 June 2025, hereinafter Resolution No. 681).
The substances in it are divided into lists according to the control measures that apply:
List I. Substances whose circulation in Russia is prohibited, except in the cases that 3-FZ expressly allows.
List II. Narcotic drugs and psychotropic substances with restricted circulation.
List III. Psychotropic substances with restricted circulation, for which some control measures may be waived.
List IV. Precursors (substances often used in the production, manufacture and processing of narcotic drugs and psychotropic substances) with restricted circulation, divided into three tables.
Substances of Lists II and III that are registered in Russia under the legislation on the circulation of medicines are used for medical purposes. Individual entrepreneurs who carry out medical activities may not use these substances. Treatment of drug addiction with narcotic drugs and psychotropic substances of List II is prohibited.
A license is required for each type of activity in Table 2.
Table 2. Who may carry out activities with substances of Lists II and III
| Type of activity | List II | List III |
|---|---|---|
| Production (serial obtaining of substances from chemicals or plants) | State unitary enterprises and state institutions whose property is in federal ownership, within state quotas and under a license for the production of specific substances | Enterprises and institutions of any form of ownership under a license for the production of specific substances |
| Manufacture (obtaining ready-to-use forms of substances or medicines containing them) | State unitary enterprises and state institutions, and also municipal unitary enterprises and municipal institutions of the municipal healthcare system, if they manufacture substances when medical organizations of the municipal healthcare system provide medical care to citizens, under a license for the manufacture of specific substances | Enterprises and institutions of any form of ownership under a license for the manufacture of specific substances |
| Distribution (receipt by legal entities of specific substances, in the established amounts, for circulation) | State unitary enterprises and state institutions | Legal entities of any form of ownership with a license |
| Import and export | MSU for use for scientific and educational purposes and in expert activities, and also state unitary enterprises, each with a license for the right to import (export) | Legal entities of any form of ownership holding a license for the right to import (export) |
| Storage | Legal entities with a license, in specially equipped premises | Legal entities with a license, in specially equipped premises |
| Dispensing (transfer by a legal entity within its structure and to individuals for medical use) and sale (sale or transfer by one legal entity to another) | Legal entities of any form of ownership with a license | Legal entities of any form of ownership with a license |
Circulation license
Activities in the circulation of narcotic drugs, psychotropic substances and precursors entered in Lists I, II and III and in Table I of List IV of the Controlled Substances List are licensed. The Licensing Regulation contains a list of the works and services that make up this activity.
The license is issued by one of two authorities:
The Federal Service for Surveillance in Healthcare (Roszdravnadzor) issues licenses for the circulation of substances of Lists I, II and III to organizations engaged in wholesale trade in medicines and to pharmacy organizations subordinate to federal executive bodies. For other licensees, Roszdravnadzor monitors compliance with licensing requirements (except licensees that have filed applications to amend the register of licenses) and may suspend, resume and revoke licenses.
Executive authorities of the constituent entities of the Russian Federation issue licenses for the circulation of substances of Lists I, II and III to all other legal entities. They also issue licenses to foreign legal entities that take part in an international medical cluster project and that acquire, store and use substances of Lists II and III for medical purposes.
An application for a license is filed as an electronic document through the Unified Portal of State and Municipal Services and signed with an electronic signature. For some of the works and services in the list in the Licensing Regulation, the application states the specific narcotic drugs and psychotropic substances. The licensing authority decides whether to grant or refuse the license within up to 8 working days from the date the application is received, and within up to 20 working days for closed administrative-territorial entities. A decision on amending the register of licenses is made within up to 6 working days from the date the application is accepted, and within up to 20 working days for closed administrative-territorial entities.
The license applicant’s compliance with the requirements is assessed in the form of an on-site assessment. For a licensee, an on-site assessment is mandatory if a new address of activity is entered in the register of licenses; in other cases it is carried out remotely, by audio and (or) video communication. The licensee states the new address and the new work or service in an application to amend the register of licenses.
Product registration and information in the register
Decision of the Council of the Eurasian Economic Commission (EEC) No. 78 of 3 November 2016 (as amended on 26 November 2025, hereinafter Decision No. 78) approved the Rules for Registration and Regulatory Review of Medicines for Medical Use. These Rules name narcotic and psychotropic products among products with hard-to-obtain samples. The applicant does not submit product samples, reference standards, specific reagents and other materials if testing in an expert organization is impossible because the samples are hard to obtain, including when they are classified as orphan, high-tech, radiopharmaceutical, narcotic or psychotropic products, or products for treating high-cost nosologies because of their high cost. This provision applies in the mutual recognition procedure and the decentralized procedure, and to major Type II variations.
The State Register of Medicines shows separately whether a medicinal product contains narcotic drugs, psychotropic substances and their precursors that are subject to control in Russia. Federal Law No. 61-FZ of 12 April 2010 «On the Circulation of Medicines» (as amended on 4 August 2026, hereinafter 61-FZ) requires this. The same mark is provided for active pharmaceutical ingredients (APIs).
Import and export
A legal entity obtains a license for the right to import (export) after it obtains a certificate (if the substances are classified as medicines) and a permit from the authorized federal bodies. The license is issued by the federal body that carries out state regulation of foreign trade activity, in accordance with Federal Law No. 164-FZ of 8 December 2003 «On the Fundamentals of State Regulation of Foreign Trade Activity» (hereinafter 164-FZ). The certificate and the permit cannot be transferred to another legal entity. Individual entrepreneurs may not import or export these substances.
The application for a certificate and a permit states the purposes of the import (export), data on the legal entity, the manufacturer and the consignee, the International Nonproprietary Name (INN), the dosage form, whether there is a quality certificate, the quantity in the batch, the deadlines, the type of transport, the place and time of import of the batch and other data, in the procedure set by the Government. Customs authorities make a note on the back of the license when each batch arrives. If the quantity in a batch does not match the quantity in the license, information about this is reported to the competent authority of the exporting or importing state. If the 3-FZ requirements for import and export are violated, the substances are subject to confiscation.
These 3-FZ requirements do not apply to export for humanitarian aid and emergency relief, to import and export of substances seized from illicit circulation, to import and export by military units, or to emergency medical packs, sets, kits and first-aid kits for providing first aid that contain substances of Lists II and III. For such kits, the law of the Eurasian Economic Union (EAEU), the international treaties of Russia and the legislation of Russia apply.
At the EAEU level, an authorization procedure applies to the import into the customs territory of the Union and the export from it of substances in Section 2.12 of the single list of goods subject to non-tariff regulation measures (Decision of the EEC Board No. 30 of 21 April 2015, as amended on 7 April 2026, hereinafter Decision No. 30). The list of substances in this section changes: Decision of the EEC Board No. 45 of 7 April 2026 (hereinafter Decision No. 45) added new substances of Lists I and II to it. Decision No. 45 entered into force 30 calendar days after publication, that is, on 10 May 2026.
The procedure for import and export is set by the Regulation that is part of Decision No. 30 (hereinafter the Import and Export Regulation):
Substances may be imported and exported with a license issued under the Instruction on completing applications for licenses for export or import of certain types of goods and on issuing such licenses. This Instruction is part of the Rules for Issuing Licenses and Permits for Export and (or) Import of Goods, approved by Decision of the EEC Council No. 125 of 24 November 2023 (hereinafter Decision No. 125).
The license is presented to the customs authority of a member state when the substances arrive in the customs territory of the Union. The license is also needed to place the substances under the customs procedures of release for domestic consumption and export.
A license is not required when individuals import and export a limited quantity of substances in the form of medicines for personal use on medical grounds, with supporting medical documents, or in the other cases listed in the Import and Export Regulation.
Placing the substances under the customs procedures of customs warehouse, processing in the customs territory, processing outside the customs territory, processing for domestic consumption, temporary import (admission), temporary export, duty-free trade, destruction, refusal in favor of the state, free customs zone, free warehouse, re-import and re-export is not allowed.
The quantity of narcotic drugs under international control under the Single Convention on Narcotic Drugs of 1961 that is stated in an export license must not exceed the annual estimates of the requirements of the importing country that the International Narcotics Control Board has approved and published. For psychotropic substances under international control under the Convention on Psychotropic Substances of 1971, the limit is set by the estimates of annual medical and scientific requirements for the importing country, published by the same Board, for substances included in Schedules II, III and IV of that Convention.
The applicant reports on the fulfillment of the license to the authorized body of the member state under the rules of Decision No. 125.
Decision No. 125 enters into force 60 calendar days after the date on which the Protocol Amending the Treaty on the Eurasian Economic Union, signed on 25 May 2023 (hereinafter the Protocol of 25 May 2023), enters into force. The Protocol of 25 May 2023 enters into force on the date the depositary (the EEC, which keeps the original of the Protocol) receives the last written notification that the member states have completed their internal procedures. The Protocol of 25 May 2023 entered into force on 25 April 2024, so Decision No. 125 entered into force on 24 June 2024. On the same day, the provision of the Protocol that repeals the former Rules for Issuing Licenses and Permits also entered into force. The version of Decision No. 125 of 29 November 2024 applies from 15 May 2025.
Neither 3-FZ nor the Import and Export Regulation says whether it is one license or two: 3-FZ speaks of a license for the right to import (export), and the Import and Export Regulation speaks of a license issued under the Instruction to Decision No. 125.
3-FZ prohibits the transit of narcotic drugs, psychotropic substances and their precursors through the territory of Russia. At the same time, the Import and Export Regulation provides for placing these substances under the customs transit procedure and names the documents for two cases. If the substances are carried from the place of arrival in the customs territory of the Union to the place of departure from it, the customs authority at the place of arrival receives a certified copy of the permit for export of the batch issued by the competent authority of the exporting state, or an official notification from this authority that a permit is not required. If the substances are carried from the place of arrival to an internal customs authority or from an internal customs authority to the place of departure, the customs authority receives the license that is needed to place the substances under the customs procedures of release for domestic consumption and export. Neither of the two acts says how the transit prohibition in 3-FZ relates to these rules of the Import and Export Regulation.
Decision of the EEC Board No. 9 of 21 January 2025 (hereinafter Decision No. 9) adds a new rule to the Import and Export Regulation: the import of narcotic drugs, psychotropic substances and their precursors in the form of medicines, as e-commerce goods purchased by individuals, is prohibited. Decision No. 9 enters into force 30 calendar days after publication, but not earlier than the entry into force of the Protocol Amending the Treaty on the Customs Code of the EAEU of 11 April 2017, signed on 25 December 2023. As of 14 October 2026 this Protocol has not entered into force, so the prohibition does not apply.
Distribution plan and applications
Narcotic drugs and psychotropic substances for medicine and veterinary medicine are distributed under a distribution plan that the Russian Ministry of Industry and Trade approves every year. The plan is prepared in this order:
Legal entities that produce, manufacture and import substances, except pharmacy organizations that manufacture medicines containing these substances, submit information on the planned volumes of production, manufacture and import to the Russian Ministry of Industry and Trade no later than 15 August.
Organizations subordinate to federal executive bodies or registered in a constituent entity of Russia submit an application no later than 15 September to the authorized organization, that is, the legal entity that distributes the substances. The need is calculated under the standards of the Russian Ministry of Health and, for veterinary medicine, under the standards of the Russian Ministry of Agriculture. The justification of the calculation is stated in the application.
The authorized organization sends a consolidated application to the federal executive body or the body of the constituent entity, and that body submits it to the Russian Ministry of Industry and Trade no later than 15 October.
The Russian Ministry of Industry and Trade approves the plan no later than 1 December and amends it every quarter, no later than the 15th day of the month after the quarter. Copies of the plan are sent no later than 15 December to the Russian Ministry of Internal Affairs, the Russian Ministry of Health, the federal executive bodies and the authorized bodies of constituent entities of Russia that submitted consolidated applications, and to the legal entities included in the plan that produce, manufacture and import substances. After amendments, copies are sent within 15 working days from the date of the amendments.
Legal entities that submit information on planned volumes (they produce, manufacture and import substances) sell the substances used for medical purposes and in veterinary medicine to authorized organizations under the approved plan. Substances for production, manufacture, scientific and educational purposes, expert activities and medical examination are sold under a contract with a legal entity that holds a license. One condition of the contract is a ban on selling the substances to third parties.
What to do
Determine the type of activity and the authority that issues the license. Check the type of activity and the list of the substance against Table 2: the circle of organizations that may carry out the activity depends on both. Roszdravnadzor issues the license for the circulation of substances of Lists I, II and III to organizations engaged in wholesale trade in medicines and to pharmacy organizations subordinate to federal executive bodies, and the executive authority of the constituent entity of Russia issues it to all other legal entities.
File the application in electronic form. The application is filed through the Unified Portal of State and Municipal Services and signed with an electronic signature, and for some works and services it states specific substances. The decision is made within up to 8 working days from the date the application is received, and within up to 20 working days for closed administrative-territorial entities. A new address of activity is stated in an application to amend the register of licenses, and an on-site assessment is mandatory for it.
Determine who may import the product. For substances of Lists I and II this is MSU or a state unitary enterprise, and for List III a legal entity with a license for the right to import (export). The certificate and the permit cannot be transferred to another legal entity. So before signing a contract, ask the importer for the certificate, the permit and the license for the right to import (export), and check the license against the requirements of 3-FZ and the Import and Export Regulation: neither act says whether one document or two is issued.
Put the end dates of the acts and the distribution plan deadlines in the calendar. Resolution No. 1871 is valid until 1 March 2028, and Resolution No. 1007 until 1 September 2028 (Table 1). The distribution plan deadlines under Resolution No. 1871 are: information on planned volumes no later than 15 August, applications no later than 15 September and consolidated applications no later than 15 October.
Licensing is governed by Resolution No. 1007, distribution by Resolution No. 1871, and import and export by 3-FZ and EAEU law.
Resolution No. 1871 is valid until 1 March 2028, and Resolution No. 1007 until 1 September 2028.
Regulatory framework:
1. Federal Law No. 3-FZ of 8 January 1998 «On Narcotic Drugs and Psychotropic Substances» (as amended on 27 October 2025, applicable from 1 September 2026)
2. Federal Law No. 61-FZ of 12 April 2010 «On the Circulation of Medicines» (as amended on 4 August 2026)
3. Decision of the Council of the Eurasian Economic Commission No. 78 of 3 November 2016 «On the Rules for Registration and Regulatory Review of Medicines for Medical Use» (as amended on 26 November 2025)
4. Decision of the Board of the Eurasian Economic Commission No. 30 of 21 April 2015 «On Non-Tariff Regulation Measures» (as amended on 7 April 2026)
5. Decision of the Board of the Eurasian Economic Commission No. 45 of 7 April 2026 «On Amending Section 2.12 of the List of Goods Subject to the Authorization Procedure for Import into the Customs Territory of the Eurasian Economic Union and (or) Export from the Customs Territory of the Eurasian Economic Union»
6. Decision of the Board of the Eurasian Economic Commission No. 9 of 21 January 2025 «On Amending Decision of the Board of the Eurasian Economic Commission No. 30 of 21 April 2015» (not in force as of 14 October 2026)
7. Protocol Amending the Treaty on the Customs Code of the Eurasian Economic Union of 11 April 2017, signed in Saint Petersburg on 25 December 2023 (not in force as of 14 October 2026)
8. Protocol Amending the Treaty on the Eurasian Economic Union of 29 May 2014, signed in Moscow on 25 May 2023
9. Federal Law No. 164-FZ of 8 December 2003 «On the Fundamentals of State Regulation of Foreign Trade Activity»
10. Decision of the Council of the Eurasian Economic Commission No. 125 of 24 November 2023 «On Approval of the Rules for Issuing Licenses and Permits for Export and (or) Import of Goods Included in the Single List of Goods Subject to Non-Tariff Regulation Measures in Trade with Third Countries» (as amended on 29 November 2024)
11. Resolution of the Government of the Russian Federation No. 681 of 30 June 1998 «On Approval of the List of Narcotic Drugs, Psychotropic Substances and Their Precursors Subject to Control in the Russian Federation» (as amended on 11 June 2025)
12. Resolution of the Government of the Russian Federation No. 1007 of 2 June 2022 «On Licensing of Activities in the Circulation of Narcotic Drugs, Psychotropic Substances and Their Precursors and the Cultivation of Narcotic Plants» (as amended on 13 June 2024)
13. Resolution of the Government of the Russian Federation No. 1871 of 30 October 2021 «On Approval of the Rules for the Distribution, Sale and Dispensing of Narcotic Drugs and Psychotropic Substances and the Sale and Dispensing of Their Precursors, and on Recognizing Certain Acts and Individual Provisions of Certain Acts of the Government of the Russian Federation as Repealed»
14. Resolution of the Government of the Russian Federation No. 1085 of 22 December 2011 «On Licensing of Activities in the Circulation of Narcotic Drugs, Psychotropic Substances and Their Precursors and the Cultivation of Narcotic Plants»
15. Resolution of the Government of the Russian Federation No. 558 of 26 July 2010 «On the Procedure for the Distribution, Dispensing and Sale of Narcotic Drugs and Psychotropic Substances»